Morgan Stanley’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.8M | Sell |
|
|||||
|
2025
Q2 | $19.4M | Buy |
|
|||||
|
2025
Q1 | $5.15M | Buy |
|
|||||
|
2024
Q4 | $3.4M | Buy |
|
|||||
|
2024
Q3 | $1.44M | Buy |
|
|||||
|
2024
Q2 | $779K | Sell |
|
|||||
|
2024
Q1 | $1.44M | Sell |
|
|||||
|
2023
Q4 | $1.67M | Buy |
|
|||||
|
2023
Q3 | $469K | Buy |
|
|||||
|
2023
Q2 | $343K | Sell |
|
|||||
|
2023
Q1 | $361K | Buy |
|
|||||
|
2022
Q4 | $197K | Sell |
|
|||||
|
2022
Q3 | $110K | Sell |
|
|||||
|
2022
Q2 | $232K | Sell |
|
|||||
|
2022
Q1 | $714K | Sell |
|
|||||
|
2021
Q4 | $2.7M | Sell |
|
|||||
|
2021
Q3 | $4.24M | Sell |
|
|||||
|
2021
Q2 | $10.1M | Sell |
|
|||||
|
2021
Q1 | $11.3M | Buy |
|
|||||
|
2020
Q4 | $729K | Sell |
|
|||||
|
2020
Q3 | $3.01M | Buy |
|
|||||
|
2020
Q2 | $2.91M | Buy |
|
|||||
|
2020
Q1 | $1.35M | Sell |
|
|||||
|
2019
Q4 | $6.23M | Sell |
|
|||||
|
2019
Q3 | $4M | Sell |
|
|||||
|
2019
Q2 | $5.85M | Sell |
|
|||||
|
2019
Q1 | $10.9M | Buy |
|
|||||
|
2018
Q4 | $5.72M | Sell |
|
|||||
|
2018
Q3 | $16.7M | Buy |
|
|||||
|
2018
Q2 | $13.9M | Buy |
|
|||||
|
2018
Q1 | $11.2M | Buy |
|
|||||
|
2017
Q4 | $11.4M | Buy |
|
|||||
|
2017
Q3 | $14M | Buy |
|
|||||
|
2017
Q2 | $10.1M | Sell |
|
|||||
|
2017
Q1 | $8.01M | Buy |
|
|||||
|
2016
Q4 | $8.48M | Buy |
|
|||||
|
2016
Q3 | $3.05M | Buy |
|
|||||
|
2016
Q2 | $1.66M | Sell |
|
|||||
|
2016
Q1 | $2.11M | Buy |
|
|||||
|
2015
Q4 | $1.28M | Sell |
|
|||||
|
2015
Q3 | $1.09M | Buy |
|
|||||
|
2015
Q2 | $496K | Sell |
|
|||||
|
2015
Q1 | $620K | Sell |
|
|||||
|
2014
Q4 | $1.44M | Sell |
|
|||||
|
2014
Q3 | $6.7M | Sell |
|
|||||
|
2014
Q2 | $11M | Buy |
|